[Federal Register Volume 80, Number 249 (Tuesday, December 29, 2015)]
[Notices]
[Pages 81344-81345]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-32658]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5
U.S.C., as amended. The grant and contract applications and the
discussions could disclose confidential trade secrets or commercial
property such as patentable material, and personal information
concerning individuals associated with the grant and contract
applications, the disclosure of which would constitute a clearly
unwarranted invasion of personal privacy.
Name of Committee: National Cancer Institute Special Emphasis
Panel; NCI Omnibus R03 & R21 SEP-2.
Date: February 1-2, 2016.
Time: 8:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Embassy Suites Hotel Chevy Chase Pavilion, 4300 Military
Road NW., Washington, DC 20015.
Contact Person: Eun Ah Cho, Ph.D., Scientific Review Officer,
Special Review Branch Division of Extramural Activities, National
Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W106,
Bethesda, MD 20892-9750, 240-276-6342, [email protected].
Name of Committee: National Cancer Institute Special Emphasis
Panel; Validation of Mobile Technologies for Clinical Assessment,
Monitoring and Intervention.
Date: February 2, 2016.
Time: 9:30 a.m. to 5:30 p.m.
Agenda: To review and evaluate contract applications.
Place: National Cancer Institute Shady Grove, 9609 Medical
Center Drive, Room 5E030, Rockville, MD 20850, (Telephone Conference
Call).
Contact Person: Scott A. Chen, Ph.D., Scientific Review Officer,
Research and Technology and Contract Review Branch, Division of
Extramural Activities, National Cancer Institute, NIH, 9609 Medical
Center Drive, Room 7W604, Rockville, MD 20850, 240-276-6038,
[email protected],
Name of Committee: National Cancer Institute Special Emphasis
Panel; Modulating Microbiome for Cancer Therapy.
Date: February 17, 2016.
Time: 1:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate contract applications.
Place: National Cancer Institute Shady Grove, 9609 Medical
Center Drive, Room 7W554, Rockville, MD 20850, (Telephone Conference
Call).
[[Page 81345]]
Contact Person: Christopher L. Hatch, Ph.D., Chief, Program
Coordination & Referral Branch, Division of Extramural Activities,
National Cancer Institute, NIH, 9609 Medical Center Drive, Room
7W554, Rockville, MD 20850, 240-276-6454, [email protected].
Name of Committee: National Cancer Institute Special Emphasis
Panel; The Pancreatic Cancer Detection Consortium.
Date: February 18, 2016.
Time: 10:00 a.m. to 2:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Cancer Institute Shady Grove, 9609 Medical
Center Drive, Room 7W530, Rockville, MD 20850, (Telephone Conference
Call).
Contact Person: Shamala K. Srinivas, Ph.D., Scientific Review
Officer, Office of Referral, Review and Program Coordination,
Division of Extramural Activities, National Cancer Institute, NIH,
9609 Medical Center Drive, Room 7W530, Bethesda, MD 20892-9750, 240-
276-6442, [email protected].
Name of Committee: National Cancer Institute Special Emphasis
Panel; Cell and Animal Models for Researching Disparities.
Date: February 29, 2016.
Time: 12:00 p.m. to 2:30 p.m.
Agenda: To review and evaluate contract applications.
Place: National Cancer Institute Shady Grove, 9609 Medical
Center Drive, Room 7W554, Rockville, MD 20850, (Telephone Conference
Call).
Contact Person: Christopher L. Hatch, Ph.D., Chief, Program
Coordination & Referral Branch, Division of Extramural Activities,
National Cancer Institute, NIH, 9609 Medical Center Drive, Room
7W554, Rockville, MD 20850, 240-276-6454, [email protected].
Name of Committee: National Cancer Institute Special Emphasis
Panel; Biomarkers of Adverse Reactions to RT.
Date: February 29-March 1, 2016.
Time: 11:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate contract applications.
Place: National Cancer Institute Shady Grove, 9609 Medical
Center Drive, Room 4W032/5E030, Rockville, MD 20852, (Telephone
Conference Call).
Contact Person: Kenneth Bielat, Ph.D., Scientific Review
Officer, Research and Technology and Contract Review Branch,
Division of Extramural Activities, National Cancer Institute, NIH,
9609 Medical Center Drive, Room 7W244, Rockville, MD 20850, 240-276-
6373, [email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.392,
Cancer Construction; 93.393, Cancer Cause and Prevention Research;
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer
Control, National Institutes of Health, HHS)
Dated: December 22, 2015.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2015-32658 Filed 12-28-15; 8:45 am]
BILLING CODE 4140-01-P